Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

The Medicines Company Company Profile (NASDAQ:MDCO)

Consensus Ratings for The Medicines Company (NASDAQ:MDCO) (?)
Ratings Breakdown: 4 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $30.08 (14.43% upside)

Current Analysts' Coverage Summary for The Medicines Company (NASDAQ:MDCO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/16/2015Citigroup Inc.Set Price TargetHold$30.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
4/10/2015MizuhoLower Price TargetNeutral$30.00 -> $27.50ViewTweet This Rating  Share This Rating on StockTwits
2/20/2015ZacksReiterated RatingNeutral -> Neutral$30.00ViewTweet This Rating  Share This Rating on StockTwits
1/21/2015Leerink SwannUpgradeMarket Perform -> Outperform$24.00 -> $31.00ViewTweet This Rating  Share This Rating on StockTwits
11/20/2014Credit SuisseUpgradeNeutral -> Outperform$27.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2014Bank of AmericaLower Price TargetBuy -> Neutral$37.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
4/2/2014Piper JaffrayDowngradeOverweight -> Neutral$41.00 -> $29.00ViewTweet This Rating  Share This Rating on StockTwits
3/31/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
2/13/2014RBC CapitalLower Price TargetOutperform$50.00 -> $44.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014Jefferies GroupDowngradeBuy -> Hold$38.50 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2013OppenheimerInitiated CoverageOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 5/6/2013 forward)